Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 3.500
+0.144 (4.29%)
Aug 13, 2025, 11:44 AM CET
Genfit Market Cap
Genfit has a market cap or net worth of €167.11 million as of August 13, 2025. Its market cap has decreased by -16.04% in one year.
Market Cap
167.11M
Enterprise Value
147.46M
Revenue
70.69M
Ranking
n/a
PE Ratio
111.87
Stock Price
€3.50
Market Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 167.11M, an increase of 14.41%. That is a compound annual growth rate of 0.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 166.12M | -5.76% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | 154.93M | -77.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 116.07B |
| Sanofi | 98.69B |
| Sartorius Stedim Biotech | 16.23B |
| bioMérieux | 14.69B |
| Eurofins Scientific SE | 11.77B |
| Ipsen | 8.72B |
| ABIVAX Société Anonyme | 4.59B |
| Virbac | 2.76B |